Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 29.09.2025 8 Am J Dermatopathol 1 Am J Ophthalmol 13 Br J Dermatol 4 Cancer 6 Clin Exp Dermatol 5 Int J Dermatol 2 J Dermatol 6 J Invest Dermatol 2 Lancet 1 Mycoses 1 Plast Reconstr Surg 1 PLoS Comput Biol 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. SANGANI KA, Lee V, Schroedl L, Shea CR, et al
   Progressive Immunotherapy-Related Mucocutaneous Eruption: A Mimicker of SJS-TEN.
   Am J Dermatopathol. 2025;47:750-753.
   PubMed         Abstract available
   
   
2. BRAMBERT L, Bhukhan A, Dukharan V, Mitropoulos P, et al
   Bumps on My Head-A Case of Acute T-Cell Lymphoblastic Lymphoma.
   Am J Dermatopathol. 2025;47:803-807.
   PubMed         Abstract available
   
   
3. NGUYEN AJ, Guo RR, Peters MS
   Utility of Immunohistochemistry in Diagnosis of Papillary Eccrine Adenoma/Tubular Apocrine Adenoma (PEA/TAA).
   Am J Dermatopathol. 2025;47:808-809.
   PubMed         Abstract available
   
   
4. HIRAKI T, Takai T, Iwahashi Y, Murata SI, et al
   Retrospective Analysis of the Utility of Polymerase Chain Reaction-Reverse Sequence-Specific Oligonucleotide (GENOSEARCH HPV31) and Human Papillomavirus Immunohistochemistry (BSB-66) in the Diagnosis of Digital Papillary Adenocarcinoma.
   Am J Dermatopathol. 2025;47:775-781.
   PubMed         Abstract available
   
   
5. MARTINEZ-SERNANDEZ V, Oliva-Fernandez JA, Jimenez-Perez AB, Lopez-Martinez D, et al
   Venous Malformation-Like Kaposi Sarcoma: Revisiting a Known Variant.
   Am J Dermatopathol. 2025 Sep 22. doi: 10.1097/DAD.0000000000003134.
   PubMed        
   
   
6. CAPUTO V, Stabile G, Veraldi S, Rongioletti F, et al
   A Curious Diagnosis of "Parasite Eggs" in the Skin: Challenge.
   Am J Dermatopathol. 2025;47:e111-e112.
   PubMed        
   
   
7. STICOVA E, Hugo J
   Cutaneous Panniculitis in Q Fever: A Case of Diagnostic Granulomas.
   Am J Dermatopathol. 2025;47:816-817.
   PubMed        
   
   
8. CAPUTO V, Stabile G, Veraldi S, Rongioletti F, et al
   A Curious Diagnosis of "Parasite Eggs" in the Skin.
   Am J Dermatopathol. 2025;47:810.
   PubMed        
   
   

   
   Am J Ophthalmol

9. WANG CY, Lin TY, Yu Wang T, Chi CC, et al
   Ocular comorbidities of psoriasis: A systematic review and meta-analysis of observational studies.
   Am J Ophthalmol. 2025 Sep 18:S0002-9394(25)00494.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

10. WHITEMAN DC
    BRAF testing for melanoma in England.
    Br J Dermatol. 2025 Sep 12:ljaf373. doi: 10.1093.
    PubMed        
    
    
11. FOSTER J, Sarlashkar P, Lu G, Teske N, et al
    Disparities in online patient education materials for rheumatic skin diseases.
    Br J Dermatol. 2025 Sep 15:ljaf371. doi: 10.1093.
    PubMed        
    
    
12. ZHANG L, Wang M, Zhang L, Liang Y, et al
    Efficacy and Safety of Pumecitinib Gel for Treating Mild-to-moderate Atopic Dermatitis: a Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Phase IIb Clinical Trial.
    Br J Dermatol. 2025 Sep 18:ljaf363. doi: 10.1093.
    PubMed         Abstract available
    
    
13. TAN W, Chen Z, Xu M, Chen J, et al
    Single-cell RNA sequencing reveals transcriptomic landscape and potential targets for large/giant congenital melanocytic nevi.
    Br J Dermatol. 2025 Sep 20:ljaf360. doi: 10.1093.
    PubMed         Abstract available
    
    
14. FOSTER EL, Davis MI, Li AX, Kottner J, et al
    Identification of key symptoms for a core outcome set for research in vulvar lichen sclerosus: a CORALS symptom domain initiative.
    Br J Dermatol. 2025 Sep 22:ljaf374. doi: 10.1093.
    PubMed         Abstract available
    
    
15. WARREN RB, de Bruin-Weller M, Tsianakas A, Khemis A, et al
    Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
    Br J Dermatol. 2025 Sep 22:ljaf285. doi: 10.1093.
    PubMed         Abstract available
    
    
16. YIU ZZN
    Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis.
    Br J Dermatol. 2025 Sep 23:ljaf316. doi: 10.1093.
    PubMed        
    
    
17. PALLER AS, Teng J, Mazereeuw-Hautier J, Hernandez-Martin A, et al
    Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
    Br J Dermatol. 2025;193:592-618.
    PubMed         Abstract available
    
    
18. AKIYAMA M, Choate K, Hernandez-Martin A, Aldwin-Easton M, et al
    Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
    Br J Dermatol. 2025;193:619-641.
    PubMed         Abstract available
    
    
19. JOPP H, Kraft A, Hoffmann B, Merkel R, et al
    Preclinical validation of PKC412 as a therapy candidate for epidermolysis bullosa simplex across multiple keratin pathogenic variants.
    Br J Dermatol. 2025;193:741-757.
    PubMed         Abstract available
    
    
20. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
    Br J Dermatol. 2025;193:653-661.
    PubMed         Abstract available
    
    
21. MAI JZ, Kitahara CM, Sargen MR, Little MP, et al
    Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US Radiologic Technologists cohort.
    Br J Dermatol. 2025;193:678-686.
    PubMed         Abstract available
    
    
22. KWATRA SG, Pereira MP, Misery L, Mollanazar NK, et al
    Prurigo nodularis: disease burden, clinical features and approach to management.
    Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer

23. ISLAMI F, Wiese D, Schafer EJ, Sung H, et al
    Stage-specific cancer survival in Black and White persons by urbanicity of county of residence, United States, 2015-2021.
    Cancer. 2025;131:e70073.
    PubMed         Abstract available
    
    
24. RIBI K, Cole BF, Fleming GF, Walley BA, et al
    Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
    Cancer. 2025;131:e70094.
    PubMed         Abstract available
    
    
25. COLAES R, Schroyen G, Radwan A, Gavrila Laic RA, et al
    Unveiling the impact of chemotherapy in patients with breast cancer: A longitudinal study on peripheral inflammation, multimodal magnetic resonance imaging, and cognition.
    Cancer. 2025;131:e70095.
    PubMed         Abstract available
    
    
26. SHAFFER KM, Daniel KE, Wiseman KP, Ritterband LM, et al
    Prospective associations between sleep quality and sexual satisfaction in distressed breast cancer survivors: Secondary analysis from the Apps Reaching Cancer Survivors randomized trial.
    Cancer. 2025;131:e70093.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

27. HANDA S, Dev A, Bishnoi A, De D, et al
    Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohort.
    Clin Exp Dermatol. 2025 Sep 15:llaf420. doi: 10.1093.
    PubMed         Abstract available
    
    
28. ASLAM F, Morrison PJ, O'Kane D
    Multidisciplinary management of congenital ichthyosis with confetti: a case report of the clinical course and genetic diagnosis in a patient with a KRT10 mutation.
    Clin Exp Dermatol. 2025 Aug 5:llaf365. doi: 10.1093.
    PubMed        
    
    
29. SHENOUDA C, McMullen E, Xiong G, Gupta S, et al
    Quality and readability of online resources for atopic dermatitis: a cross-sectional analysis.
    Clin Exp Dermatol. 2025 Sep 18:llaf419. doi: 10.1093.
    PubMed        
    
    
30. JAE JEON J, Kim YH, Son H, Lee JY, et al
    Incidence of cutaneous malignancy following the concomitant use of cyclosporine and narrowband UV-B phototherapy in patients with vitiligo.
    Clin Exp Dermatol. 2025 Sep 23:llaf428. doi: 10.1093.
    PubMed         Abstract available
    
    
31. MANN N, Bleiker TO, Smith J
    The importance of screening for Staphylococcus aureus in skin reactions to diabetes technology: not a rash decision.
    Clin Exp Dermatol. 2025 Aug 5:llaf368. doi: 10.1093.
    PubMed        
    
    
32. WANG XM, Furness A, Heelan K
    Cutaneous toxicities in patients with metastatic uveal melanoma receiving tebentafusp: a retrospective review. The experience of a single large specialist institution.
    Clin Exp Dermatol. 2025 Sep 24:llaf426. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

33. TRAN TS, Le DV, Jacobs JC, Nguyen TM, et al
    Post-Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System.
    Int J Dermatol. 2025 Sep 24. doi: 10.1111/ijd.70082.
    PubMed        
    
    
34. ZHOU L, Gober M, Chu EY
    Amelanotic Superficial Spreading Melanoma Mimicking a Papulosquamous Eruption.
    Int J Dermatol. 2025 Sep 23. doi: 10.1111/ijd.70086.
    PubMed        
    
    
35. WILLIAMS MCG, Turner N, Mendez L, Leventhal JS, et al
    Clinicopathological Challenge: Fixed Urticaria-Like Pink Papules in a Patient With Recurrent Fevers and Arthralgias.
    Int J Dermatol. 2025 Sep 19. doi: 10.1111/ijd.70083.
    PubMed         Abstract available
    
    
36. LI S, Zheng S, Xue X, He S, et al
    Exploring the Application of Secukinumab in Patients With Linear Psoriasis and Inflammatory Linear Verrucous Epidermal Nevus: A Case Study and Mini-Review.
    Int J Dermatol. 2025 Sep 19. doi: 10.1111/ijd.70065.
    PubMed        
    
    
37. PENG B, Kuang Y, Chen M, Zhang M, et al
    Refractory Pediatric Generalized Pustular Psoriasis Successfully Treated With Spesolimab.
    Int J Dermatol. 2025 Sep 19. doi: 10.1111/ijd.70079.
    PubMed        
    
    

    
    J Dermatol

38. LIU G, Huang T, Gao XJ, Ding RL, et al
    Expression of Co-Inhibitory Molecules on Lymphocytes of Patients With Psoriasis.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17937.
    PubMed         Abstract available
    
    
39. KAMIYA K, Yamaguchi Y, Saeki H, Kodera M, et al
    Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics.
    J Dermatol. 2025 Sep 19. doi: 10.1111/1346-8138.17968.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

40. XIE J, Zhao S, Wu D, Ma C, et al
    A Metabolism-Driven Prognostic Model and PSMD14-SP1-GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma.
    J Invest Dermatol. 2025 Sep 16:S0022-202X(25)02430.
    PubMed         Abstract available
    
    
41. DUMRONGPHUTTIDECHA T, Ishikawa M, Cabezas-Wallscheid N, Sada A, et al
    Retinoic acid signaling alters the balance of epidermal stem cell populations in the skin.
    J Invest Dermatol. 2025 Sep 18:S0022-202X(25)02433.
    PubMed         Abstract available
    
    
42. SCHNEIDERMAN M
    Association of Adult Atopic Dermatitis and Repetitive Strain Injury: A U.S. Population-Based Study.
    J Invest Dermatol. 2025 Sep 19:S0022-202X(25)02435.
    PubMed        
    
    
43. ZHAO Q, Fan Z, Zhang Y, Li J, et al
    Glutamatergic Projections from the Basolateral Amygdala to Medial Prefrontal Cortex Contribute to Acute Itch Sensation Processing.
    J Invest Dermatol. 2025;145:2588-2597.
    PubMed         Abstract available
    
    
44. OLAH P, Reuvers N, Radai Z, Varadi A, et al
    Microbe-Host Interaction in Rosacea and Its Modulation through Topical Ivermectin.
    J Invest Dermatol. 2025;145:2576-2587.
    PubMed         Abstract available
    
    
45. PEREZ SM, Kabashima K, Reich K, Gilliet M, et al
    Lessons from TNF-alpha Inhibitor-Induced Alopecia Areata: Does TNF-alpha Operate as a Hair Follicle Immune Privilege Guardian under Inflammatory Conditions?
    J Invest Dermatol. 2025;145:2410-2416.
    PubMed         Abstract available
    
    

    
    Lancet

46. GOLD LS, Armstrong AW, Bissonnette R, Magnolo N, et al
    Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
    Lancet. 2025 Sep 18:S0140-6736(25)01576-4. doi: 10.1016/S0140-6736(25)01576.
    PubMed         Abstract available
    
    
47. PUIG L
    Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy.
    Lancet. 2025 Sep 18:S0140-6736(25)01675-7. doi: 10.1016/S0140-6736(25)01675.
    PubMed        
    
    

    
    Mycoses

48. TANG C, Kong X, Jansen J, Vossgroene K, et al
    Utility of MALDI-ToF MS for Recognition and Antifungal Susceptibility of Nannizzia, an Underestimated Group of Dermatophytes.
    Mycoses. 2025;68:e70117.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

49. DAIEM M, Torres-Guzman RA, Chennupati V, Gergoudis F, et al
    Skin Graftless Dorsal Metacarpal Island VY Advancement Flap versus Dorsal Rectangular Flap with Skin Grafting in 213 Simple Syndactyly Releases.
    Plast Reconstr Surg. 2025 Sep 23. doi: 10.1097/PRS.0000000000012466.
    PubMed        
    
    

    
    PLoS Comput Biol

50. NOUIRA A, Azencott CA
    Sparse multitask group Lasso for genome-wide association studies.
    PLoS Comput Biol. 2025;21:e1012734.
    PubMed         Abstract available
    
    

    
    PLoS One

51. O'CONNOR AW, Park JH, Stanton ML, Liang X, et al
    Assessment of environmental risk factors for blastomycosis during a large outbreak at a Michigan paper mill.
    PLoS One. 2025;20:e0332398.
    PubMed         Abstract available
    
    
52. TUNA BG, Keles NA, Cicekdal MB, Dogan S, et al
    Distinct transcriptomic effects of intermittent and chronic caloric restriction in mammary fat pad of a breast cancer mouse model.
    PLoS One. 2025;20:e0331898.
    PubMed         Abstract available
    
    
53. SERENO D, Kernif T, Leon R, Kahime K, et al
    Mapping unconventional Leishmania in human and animal leishmaniasis: A scoping review protocol on pathogen diversity, geographic distribution and knowledge gaps.
    PLoS One. 2025;20:e0332874.
    PubMed         Abstract available
    
    
54. SOETOMO SA, Sharp MF, Crismani W
    Differential PARP inhibitor responses in BRCA1-deficient and resistant cells in competitive co-culture.
    PLoS One. 2025;20:e0332860.
    PubMed         Abstract available
    
    
55. GOMEZ-MARTINEZ M, Arias-Merino G, Benito-Lozano J, Villaverde-Hueso A, et al
    Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0332844.
    PubMed         Abstract available
    
    
56. GUZMAN-LORITE M, Munoz-Moreno L, Marina ML, Carmena MJ, et al
    In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer.
    PLoS One. 2025;20:e0330895.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.